What Happened?
Cambridge, MA-based Avrobio Appointed Geoff MacKay as President and Chief Executive Officer
About the Company
Avrobio`s vision is to bring personalized gene therapy to the world. We aim to prevent, halt or reverse disease throughout the body with a single dose of gene therapy designed to drive durable expression of therapeutic protein, even in hard-to-reach tissues and organs including brain, muscle and bone. Our ex vivo lentiviral gene therapy pipeline includes clinical programs in Fabry disease, Gaucher disease type 1 and cystinosis, as well as preclinical programs in Hunter syndrome, Gaucher disease type 3 and Pompe disease. Avrobio is powered by our industry leading plato® gene therapy platform, our foundation designed to deliver gene therapy worldwide. We are headquartered in Cambridge, Mass., with an office in Toronto, Ontario.
About the Person
Geoff MacKay is President and Chief Executive Officer at Avrobio. Previously, Geoff held various senior HR leadership roles in the industry.
Info Source
News
Short Profile